Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model

Correction for ‘CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model’ by Qiqian Liu et al., Nanoscale Adv., 2020, 2, 5231–5241. https://doi.org/10.1039/D0NA00758G.

Detalles Bibliográficos
Autores principales: Liu, Qiqian, Liu, Hui, Sacco, Pasquale, Djaker, Nadia, Lamy de la Chapelle, Marc, Marsich, Eleonora, Li, Xiaowu, Spadavecchia, Jolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595179/
https://www.ncbi.nlm.nih.gov/pubmed/36341290
http://dx.doi.org/10.1039/d2na90075k
Descripción
Sumario:Correction for ‘CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model’ by Qiqian Liu et al., Nanoscale Adv., 2020, 2, 5231–5241. https://doi.org/10.1039/D0NA00758G.

Ejemplares similares